프로그램

Time Title Chair/Speaker
08:55-09:00 Registration
09:00-09:01 Moderator Hye Ryoun Jang
Chair of Scientific Committee of CGTI,
Samsung Medical Center,
Sungkyunkwan University School of Medicine
09:01-09:04 Opening Remarks Yun Sil Chang
Director of Cell and Gene Therapy Institute(CGTI),
Samsung Medical Center(SMC),
Director of Samsung Advanced Institute for Health Sciences and Technology(SAIHST),
Sungkyunkwan University
09:04-09:07 Welcome Address WooSeong Huh
Executive Vice President, Chief Research Officer, Samsung Medical Center
09:07-09:10 Congratulatory Address Seung Woo Park
President & CEO of Samsung Medical Center
09:10-09:15 Congratulatory Address Eunyoung Jung
Director General of Bureau of Health Industry, Ministry of Health and Welfare
09:15-09:30 Startup G-CROWN Platform Jeehun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
09:30-09:35 Discussion
Session I. Translational & Clinical Research of Cell · Gene therapy for Incurable Diseases
Chair : Yun Sil Chang (Director of CGTI, SMC, Director of SAIHST, Sungkyunkwan University)
Dongho Choi (Hanyang University College of Medicine)
09:35-10:00 OC15-Current State of the Art of Cellbased Therapy for Aging Frailty and Neuro-Cognitive Disorders Joshua M Hare
University of Miami, USA
10:00-10:05 Discussion
10:05-10:30 Cardiovascular Regeneration with iPSCs and Reprogramming Young-Sup Yoon
Yonsei University / Emory University, USA
10:30-10:35 Discussion
10:35-10:45 Break
Session II. Perspective: Advanced Technology of Cell · Gene therapy to Clinical
Chair : Ji Hyeon Ju (Seoul St. Mary's Hospital, The Catholic University of Korea)
Sang Jin Kim (Samsung Medical Center, Sungkyunkwan University School of Medicine)
10:45-11:00 Transplantation of cultivated limbal stem cell sheet in corneal blindness So-Hyang Chung
College of Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital
11:00-11:15 High-Purity Functional Corneal Endothelial Cells from Human Induced Pluripotent Stem Cells Hun Lee
Asan Medical Center, University of Ulsan College of Medicine
11:15-11:25 Discussion
11:25-12:30 Lunch
Session III. Recent Advances and Future Perspectives I
Chair : Jae Ho Kim (Pusan National University School of Medicine)
Hye Ryoun Jang (Samsung Medical Center, Sungkyunkwan University School of Medicine)
12:30-12:45 Advances in Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia: Translational and Clinical Insights So Yoon Ahn
Samsung Medical Center, Sungkyunkwan University School of Medicine
12:45-13:00 Lesson from Alveolar Regeneration Program in early lung tumor development and niche remodelling Jinwook Choi
Gwangju Institute of Science and Technology
13:00-13:15 Organoid Modelling of Human Lung Development and Cell Fate Alteration in Human Congenital Pulmonary Diseases Kyungtae Lim
Korea University
13:15-13:30 Discussion
Session IV. Recent Advances and Future Perspectives II
Chair : Oh Young Bang (Samsung Medical Center, Sungkyunkwan University School of Medicine)
Tae-Young Roh (Ewha Womans University / President of Korean Society for Extracellular Vesicles (KSEV))
13:30-13:45 From Organoid Genetics to Mosaic Genetics Bon-Kyoung Koo
Center for Genome Engineering, Institute for Basic Science
13:45-14:00 Pluripotent Stem Cell-Derived Epidermal Organoids: A Novel Model for Skin Research and Extracellular Vesicle-Based Regeneration Jungwoon Lee
Korea Research Institute of Bioscience and Biotechnology (KRIBB),
University of Science & Technology (UST)
14:00-14:15 Oral drug delivery via milk-derived extracellular vesicles Yoosoo Yang
Sungkyunkwan University
14:15-14:30 Discussion
14:30-14:40 Break
Session V. Advanced disease modeling using Gene-modified cell therapy
Chair : Byung-Ok Choi (Samsung Medical Center, Sungkyunkwan University School of Medicine)
Jeehun Lee (Samsung Medical Center, Sungkyunkwan University School of Medicine)
14:40-14:55 Engineering retroviral vectors to reduce their oncogenic potentials in gene therapy Kwang-il Lim
Sookmyung Women’s University
14:55-15:10 Advancing cell and gene therapy through microfluidics Aram Chung
Korea University
15:10-15:25 AAV engineering and AAV-mediated gene editing for neurological disorders Jae young Lee
Ajou University, School of Medicine
15:25-15:40 Discussion
Session VI. Recent Advances and Future Perspectives III
Chair : SeungKwon You (Korea University)
Keon Hee Yoo (Samsung Medical Center, Sungkyunkwan University School of Medicine)
15:40-15:55 The potential therapeutic effect of mesenchymal stem cell-derived exosomal microRNAs in bronchopulmonary dysplasia Hyeon Ho Kim
Samsung Advanced Institute for Health Sciences and Technology(SAIHST),
Sungkyunkwan University
15:55-16:10 The Path to Clinical Translation: MSC and AAV-Based Approaches for Neuromuscular Disorders Jong Wook Chang
Samsung Advanced Institute for Health Sciences and Technology(SAIHST),
Sungkyunkwan University
16:10-16:20 Discussion
Session VII. Special Lecture on Policy Act
Chair : Inho Jo (Korean Fund for Regenerative Medicine)
Yun Sil Chang (Director of CGTI, SMC, Director of SAIHST, Sungkyunkwan University)
16:20-16:40 Effects of the ARM Act Revision on the Hospital R&D So Ra Park
Regenerative Medicine Acceleration Foundation (RMAF)
16:40-17:00 The Current State and Goals of Regenerative Medicine Policy in Korea Sun-Gill Jung
Division of regenerative medicine policy in the Ministry of Health and Welfare
17:00-17:20 Application for Advanced Regenerative Medicine Treatment Protocol Review and Guidance on How to Prepare a Treatment Protocol Suwon Kim
Secretariat for Advanced Regenerative Medicine and
Advanced Biological Products Review Committee,
Ministry of Health and Welfare
17:20-17:35 Discussion
17:35- Adjourn